- Report
- December 2023
- 147 Pages
Global
From €2173EUR$2,475USD£1,899GBP
€4346EUR$4,950USD£3,798GBP
- Report
- January 2025
- 163 Pages
Global
From €2625EUR$2,990USD£2,294GBP
- Report
- August 2024
- 163 Pages
Global
From €2625EUR$2,990USD£2,294GBP
- Report
- August 2023
- 202 Pages
South Africa
From €3073EUR$3,500USD£2,686GBP
- Report
- May 2023
- 96 Pages
Asia Pacific
From €1580EUR$1,800USD£1,381GBP
From €1580EUR$1,800USD£1,381GBP
- Report
- May 2023
United States
From €1317EUR$1,500USD£1,151GBP
- Report
- January 2023
- 306 Pages
Global
From €3688EUR$4,200USD£3,223GBP
- Report
- August 2022
- 382 Pages
Global
From €3073EUR$3,500USD£2,686GBP
- Report
- July 2022
- 317 Pages
Global
From €3073EUR$3,500USD£2,686GBP
- Report
- October 2021
- 306 Pages
Global
From €3293EUR$3,750USD£2,877GBP
- Report
- April 2021
- 377 Pages
Global
From €3508EUR$3,995USD£3,065GBP
- Report
- March 2021
Global
From €3293EUR$3,750USD£2,877GBP
- Report
- May 2023
- 120 Pages
Global
From €5224EUR$5,950USD£4,565GBP
- Report
- May 2023
- 110 Pages
Global
From €5224EUR$5,950USD£4,565GBP
- Report
- November 2022
- 200 Pages
Global
From €5224EUR$5,950USD£4,565GBP
- Report
- May 2024
- 56 Pages
Global
From €2194EUR$2,499USD£1,917GBP
- Report
- May 2023
- 134 Pages
Global
From €5224EUR$5,950USD£4,565GBP
- Report
- August 2023
- 370 Pages
Global
From €2186EUR$2,490USD£1,911GBP
- Report
- July 2023
- 210 Pages
Global
From €1747EUR$1,990USD£1,527GBP

The biopharmaceuticals market is a sector of the pharmaceutical industry that focuses on the development and production of drugs derived from biological sources. These drugs are typically produced using recombinant DNA technology, which involves the manipulation of genetic material to create proteins and other molecules with therapeutic properties. Biopharmaceuticals are used to treat a wide range of diseases, including cancer, HIV/AIDS, and autoimmune disorders.
Biopharmaceuticals are typically more expensive to produce than traditional pharmaceuticals, but they offer a number of advantages, such as improved efficacy and fewer side effects. They are also more targeted, meaning they can be used to treat specific conditions more effectively.
Some of the major companies in the biopharmaceuticals market include Amgen, Biogen, Celgene, Gilead Sciences, and Novartis. These companies are involved in the development and production of a wide range of biopharmaceuticals, including monoclonal antibodies, vaccines, and gene therapies. Show Less Read more